ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,399.22
      -0.51%
      US Tech 100
      18,362.00
      -0.93%
      Dow Jones
      39,935.07
      0.20%
      Brent Oil
      81.74
      0.25%
      Bitcoin
      67,334.88
      2.35%
      Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ

      6. Biora Therapeutics Inc (BIOR) Quote

      Biora Therapeutics Inc

      Biora Therapeutics Inc (BIOR)

      NASDAQ
      0.655
      0.0018
      (0.28%)
      Closed July 25 4:00PM
      Delayed by 15 minutes
      0.6828
      0.0278
      (4.24%)
      After Hours: 7:53PM
      Delayed by 15 minutes

      Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

      Premium

      Key stats and details

      Current Price
      0.6828
      Bid
      0.655
      Ask
      0.6995
      Volume
      94,122
      0.6502 Day's Range 0.6825
      0.475 52 Week Range 3.95
      Market Cap
      24.501M
      Previous Close
      0.6532
      Open
      0.6825
      Last Trade
      7
      @
      0.655
      Last Trade Time
      Financial Volume
      $ 62,597
      VWAP
      0.665065
      Average Volume (3m)
      254,109
      Shares Outstanding
      35,883,843
      Dividend Yield
      -
      PE Ratio
      -0.19
      Earnings Per Share (EPS)
      -3.46
      Revenue
      4k
      Net Profit
      -124.12M

      About Biora Therapeutics Inc

      Progenity Inc. is regulated by the U.S. Security and Exchange Commission and incorporated in the state of Delaware. Progenity Inc is primarely in the business of services-medical laboratories. For financial reporting their fiscal year ends on December 31st. This page includes all SEC registration de... Progenity Inc. is regulated by the U.S. Security and Exchange Commission and incorporated in the state of Delaware. Progenity Inc is primarely in the business of services-medical laboratories. For financial reporting their fiscal year ends on December 31st. This page includes all SEC registration details as well as a list of all documents S-1 Prospectus Current Reports 8-K 10K Annual Reports filed by Progenity Inc.. Show more

      Sector
      Pharmaceutical Preparations
      Industry
      Pharmaceutical Preparations
      Website
      www.bicara.com
      Headquarters
      Dover, Delaware, USA
      Founded
      1970
      Biora Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker BIOR. The last closing price for Biora Therapeutics was $0.65. Over the last year, Biora Therapeutics shares have traded in a share price range of $ 0.475 to $ 3.95.

      Biora Therapeutics currently has 35,883,843 shares outstanding. The market capitalization of Biora Therapeutics is $23.44 million. Biora Therapeutics has a price to earnings ratio (PE ratio) of -0.19.

      BIOR Latest News

      More News

      FeaturedSouthern Silver Files NI43-101 Technical Report for its Updated Preliminary Economic Assessment for the Cerro Las Minitas Project

      15 hours ago

      Form 8-K - Current report

      July 18 2024
      Edgar (US Regulatory)

      Biora Therapeutics Announces Supplemental Data from Phase 1 Clinical Trial of BT-600 as Presented at KOL Event

      Pharmacokinetic and tissue data confirm NaviCap platform delivers topically through the entire colon, with lower systemic concentrations, as desired Data modeling suggests tofacitinib tissue...

      July 18 2024
      GlobeNewswire Inc.

      Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]

      July 08 2024
      Edgar (US Regulatory)

      Biora Therapeutics to Host Virtual KOL Event on NaviCap™ Targeted Oral Delivery Platform and Results from Phase 1 Clinical Trial of BT-600 on July 17, 2024

      SAN DIEGO, July 08, 2024 (GLOBE NEWSWIRE) -- Biora Therapeutics, Inc. (Nasdaq: BIOR), the biotech company reimagining therapeutic delivery, today announced further details on its virtual event...

      July 08 2024
      GlobeNewswire Inc.

      Biora Therapeutics Announces Positive Clinical Trial Results for BT-600

      Drug-device combination leverages Biora’s NaviCap™ platform to deliver tofacitinib directly to colonic tissue as a potential treatment for ulcerative colitis BT-600 was well tolerated and met all...

      July 01 2024
      GlobeNewswire Inc.

      Form 8-K - Current report

      June 14 2024
      Edgar (US Regulatory)

      Biora Therapeutics Announces Presentation on the BioJet™ Systemic Oral Delivery Platform at the Next Gen Peptide Formulation & Delivery Summit 2024

      SAN DIEGO, June 11, 2024 (GLOBE NEWSWIRE) -- Biora Therapeutics, Inc. (Nasdaq: BIOR), the biotech company that is reimagining therapeutic delivery, today announced that it will present...

      June 11 2024
      GlobeNewswire Inc.

      Form 8-K - Current report

      June 07 2024
      Edgar (US Regulatory)
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      1-0.0972-12.46153846150.780.780.62162114390.67893277CS
      40.046.222775357810.64280.790.58032429810.67966215CS
      120.04086.355140186920.6420.790.4752541090.66747386CS
      26-0.2384-25.87928788540.92121.990.4753433590.877609CS
      52-3.1072-81.98416886543.793.950.4753538271.20327016CS
      156-20.8172-96.824186046521.528.750.47596878110.00932946CS
      260-20.8172-96.824186046521.528.750.47596878110.00932946CS

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      POAIPredictive Oncology Inc
      $ 1.8696
      (74.73%)
      		161.09M
      SLRXSalarius Pharmaceuticals Inc
      $ 3.2996
      (54.19%)
      		31.33M
      PBMPsyence Biomedical Ltd
      $ 0.5865
      (49.85%)
      		82.53M
      NVNINVNI Group Ltd
      $ 1.75
      (44.63%)
      		4.12M
      CMAXCareMax Inc
      $ 5.60
      (44.33%)
      		24.81M
      TWOU2U Inc
      $ 1.51
      (-63.35%)
      		5.35M
      XPONExpion360 Inc
      $ 0.56
      (-46.15%)
      		1.29M
      KDLYKindly MD Inc
      $ 1.97
      (-38.82%)
      		860.51k
      MXLMaxLinear Inc
      $ 14.02
      (-37.10%)
      		7.73M
      CTNTCheetah Net Supply Chain Service Inc
      $ 0.3047
      (-36.78%)
      		12.8M
      NVDANVIDIA Corporation
      $ 112.28
      (-1.72%)
      		460.32M
      SQQQProShares UltraPro Short QQQ
      $ 9.37
      (3.42%)
      		248.76M
      SLNASelina Hospitality PLC
      $ 0.03755
      (-17.83%)
      		193.49M
      POAIPredictive Oncology Inc
      $ 1.8696
      (74.73%)
      		161.09M
      TSLATesla Inc
      $ 220.25
      (1.97%)
      		100.67M

      BIOR Discussion

      View Posts
      The Night Stalker The Night Stalker 2 months ago
      nice
      👍️0
      Arnold25764 Arnold25764 3 months ago
      Any possible catalyst here?
      👍️0
      Monksdream Monksdream 3 months ago
      BIOR new 52 lo
      👍️0
      Monksdream Monksdream 4 months ago
      BIOR new 52 lo
      👍️0
      Monksdream Monksdream 4 months ago
      BIOR 10Q due 3/26
      👍️0
      Monksdream Monksdream 4 months ago
      BIOR under $2
      👍️0
      glenn1919 glenn1919 5 months ago
      BIOR.................................https://stockcharts.com/h-sc/ui?s=BIOR&p=W&b=5&g=0&id=p86431144783
      👍️0
      glenn1919 glenn1919 5 months ago
      BIOR..................................https://stockcharts.com/h-sc/ui?s=BIOR&p=W&b=5&g=0&id=p86431144783
      👍️0
      Monksdream Monksdream 8 months ago
      BIOR new 52 week low
      👍️0
      Monksdream Monksdream 8 months ago
      BOIR new 52 week low
      👍️0
      Monksdream Monksdream 8 months ago
      BIOR new 52 week low
      👍️0
      TheFinalCD TheFinalCD 8 months ago
      https://finviz.com/quote.ashx?t=BIOR&p=d

      https://dilutiontracker.com/app/search/BIOR
      👍️0
      Awl416 Awl416 8 months ago
      Biora Therapeutics Announces FDA Clearance of IND Application for Drug/Device Combination BT-600 Targeting Treatment of Ulcerative Colitis
      👍️0
      retireat40 retireat40 9 months ago
      Looked good this morning at 2.66 but a crappy close.
      👍️0
      Monksdream Monksdream 12 months ago
      BIOR Barchart Bottom 100
      Biora Therapeutics Inc NASDAQ: BIOR



      GoSymbol lookup
      Health Care : Biotechnology | Small Cap ValueCompany profile
      Biora Therapeutics, Inc. is a biotechnology company, which is focused on creating smart pills designed for targeted drug delivery to the gastrointestinal (GI) tract, and needle-free delivery of biotherapeutics. The Company's therapeutics pipeline includes two therapeutic delivery platforms: NAVICAP and BIOJET. NAVICAP is a targeted oral delivery platform of therapeutics to the site of disease in the GI tract, designed to improve outcomes for patients with inflammatory bowel disease (IBD). The NAVICAP drug delivery device is an investigational, clinical-stage, single-use ingestible device approximately the size of a fish oil capsule. BIOJET is a systemic oral delivery platform of biotherapeutics designed to replace injection with needle-free, oral delivery of molecules for better management of chronic diseases. The Company's targeted therapeutics pipeline programs include NAVICAP, BT-600 and BT-001. Its systemic therapeutics pipeline programs include BIOJET, BT-200 and BT-002.
      👍️0

      Your Recent History

      NASDAQ
      BIOR
      Biora Therapeutics
      TG
      FTE
      Orange
      Delayed Upgrade Clock